About
Basic Data Updated:
4 months agoIt is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532872 and on the National Stock Exchange(NSE) under SPARC.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized ... Read More
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Financials of Sun Pharma Advanced Research Company Limited
Enhance accessibility to Sun Pharma Advanced Research Company's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Sun Pharma Advanced Research Company's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Sun Pharma Advanced Research Company Limited
Unlock and access historical data on people associated with Sun Pharma Advanced Research Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
CR
Chetan Rajpara
CFOAppointment Date: 01-Feb-2017
Status: Current
AK
Anil Kumar CEOAppointment Date: 25-May-2021
Status: Current
KD
Kajal Damania Company SecretaryAppointment Date: 22-Sep-2023
Status: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Mar 2022 | ₹25.00 Cr | Open |
Others Creation Date: 18 Feb 2021 | ₹200.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sun Pharma Advanced Research Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Pharma Advanced Research Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Sun Pharmaceutical Industries Limited
Active
31 years 2 months Sudhir Valia and Dilip Shanghvi are mutual person
Shantilal Shanghvi Foundation
Active 19 years 11 months Sudhir Valia and Dilip Shanghvi are mutual person
Recent activity within the organization
Annual General Meeting
Sun Pharma Advanced Research Company Limited last Annual general meeting of members was held on 07 Aug 2023 as per latest MCA records.
07 Aug 2023Balance Sheet
Sun Pharma Advanced Research Company Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
31 Mar 2023Charges
A charge with Others of Rs. 200.00 cr registered on 18 Feb 2021 with Charge ID 100424977 was modified on 28 Jun 2022.
28 Jun 2022Charges
A charge with Others amounted to Rs. 25.00 cr with Charge ID 100558353 was registered on 17 Mar 2022.
17 Mar 2022Charges
A charge with Others amounted to Rs. 200.00 cr with Charge ID 100424977 was registered on 18 Feb 2021.
18 Feb 2021
Recent News, Updates & Announcement
SPARC in agreement with Johns Hopkins University and IOCB for SCD153.SCD153 is the firstinclass topical formulation for the treatment of Alopecia Areata Sun Pharma Advanced Research Company has entered into an agreement with Johns Hopkins University JHU and The In.
IndiaMedToday 06 Nov 2023
- Sun Pharma Advanced Research loss widens to Rs 8199 cr in March quarter.
Business Standard 22 May 2023
- SPARC gets orphan drug designation for Phenobarbital from USFDA.
Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal seizures SPARC said in a filing to the BSE .
PTI 04 Oct 2019
- Schrödinger and SPARC Announce Collaboration to Accelerate Neurodegeneration Drug Development Program.
Business Wire 03 Dec 2018
- SPARC presents pivotal BE study for Paclitaxel Injection Concentrate for Suspension.
Business Standard 26 Nov 2018
Frequently asked questions
What is the Incorporation or founding date of Sun Pharma Advanced Research Company Limited?
